CORTI NICOLÒ

Ruolo:
Specializzando

Pubblicazioni

  • Corti, N., Ricci, E., Faltoni, M., Mezzadri, M., Fois, M., De Vito, A., et al. (2025). Impact of cefiderocol therapy on patient survival across different multi drug-resistant Gram-negative bacilli infections: insights from the SUSANA cohort. Intervento presentato a: ESCMID Global 2025. Congress of the European Society of
 Clinical Microbiology and Infectious Diseases, Vienna. Dettaglio

  • Corti, N., Ricci, E., Faltoni, M., Mezzadri, L., Fois, M., De Vito, A., et al. (2025). Impact of cefiderocol therapy on patient survival across different multidrugresistant Gram-negative bacilli infections.. Intervento presentato a: XII Workshop Nazionale CISAI, Milano. Dettaglio

  • Mezzadri, L., Ricci, E., Merli, M., Corti, N., Faltoni, M., Bandera, A., et al. (2025). Ceftazidime-avibactam plus aztreonam versus cefiderocol in the treatment of infections caused by Metallo-β lactamase-Producing Microorganisms: real-word data from the Italian cohort SUSANA. Intervento presentato a: ESCMID Global 2025. Congress of the European Society of
 Clinical Microbiology and Infectious Diseases, Vienna. Dettaglio

  • Faltoni, M., Ricci, E., Mezzadri, L., Corti, N., Bisi, L., Fois, M., et al. (2025). Comparison of meropenem-vaborbactam vs ceftazidime-avibactam in the treatment of KPC producing Klebsiella pneumoniae infections. Intervento presentato a: ESCMID Global 2025. Congress of the European Society of
 Clinical Microbiology and Infectious Diseases, Vienna. Dettaglio

  • Cavazza, G., Motto, C., Regna-Gladin, C., Travi, G., Di Gennaro, E., Peracchi, F., et al. (2024). Cerebral Infectious Opportunistic Lesions in a Patient with Acute Myeloid Leukaemia: The Challenge of Diagnosis and Clinical Management. ANTIBIOTICS, 13(5) [10.3390/antibiotics13050387]. Dettaglio